Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

<p>Video S2</p>

Сохранить в:

Библиографические подробности
Главный автор:	Alvaro Teijeira (14962650) (author)
Другие авторы:	Saray Garasa (14962653) (author), Carlos Luri-Rey (14962656) (author), Carlos de Andrea (14962659) (author), Maria Gato (14962662) (author), Carmen Molina (14962665) (author), Tsuneyasu Kaisho (14962668) (author), Assunta Cirella (14962671) (author), Arantza Azpilikueta (14962674) (author), Steffanie K. Wculek (14962677) (author), Josune Egea (14962680) (author), Irene Olivera (14962683) (author), Inmaculada Rodriguez (14962686) (author), Ana Rouzaut (14962689) (author), Vladislav Verkhusha (14962692) (author), Karmele Valencia (14962695) (author), David Sancho (14962698) (author), Pedro Berraondo (14931434) (author), Ignacio Melero (14962701) (author)
Опубликовано:	2025
Предметы:	Cancer Immuno-oncology Immunology Dendritic cells Immune responses to cancer Immunotherapy Agonist antibodies Checkpoint blockade
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы